Outcome
    Moderate Evidence

    Vitex (Chasteberry) for Hormonal Balance

    Vitex reliably lowers prolactin, which underpins its effects on cycle-related symptoms.

    Overview

    Vitex agnus castus has a long record in premenstrual complaints, and the pooled trial data look impressive at first glance. The honest reading is more measured: when the meta-analysis separated out the trials at low risk of bias, the effect shrank substantially.
    Hormonal balance is also a loose phrase, and it is worth defining. Vitex does not top up oestrogen or progesterone. Its documented action is on prolactin, which sits upstream of the luteal phase and is why cyclical breast tenderness and luteal-phase symptoms are the outcomes most consistently reported. The reasonable expectation is a modest improvement in cyclical symptoms over three menstrual cycles, in a supplement with a good tolerability record and a specific set of people who should avoid it.

    Not a fix for every hormonal symptom

    Vitex has no established role in thyroid problems, menopause-related oestrogen decline or testosterone concerns. Its evidence is in cyclical, prolactin-linked premenstrual symptoms.

    How It Works

    Diterpenes in chasteberry, principally the clerodadienols, act as dopamine D2 receptor agonists in the anterior pituitary. Dopamine is the brake on prolactin release, so stimulating those receptors lowers prolactin output.
    Mildly elevated prolactin suppresses gonadotrophin pulsatility and can blunt luteal progesterone production, a pattern associated with breast tenderness, short luteal phases and cycle irregularity. Reducing it is the proposed route to symptom improvement. Because this is a dopaminergic action rather than a hormonal replacement, effects build over cycles rather than days, and they reverse when the herb is stopped.

    Dosing & Protocol

    Trials used standardised extracts at modest doses. Higher is not better here, and the products tested were specific preparations rather than generic dried fruit powder.
    ContextDoseFormTiming
    Standard trial dose20-40 mg dailyStandardised dried extractMorning, continuously through the cycle
    Prolactin-linked symptoms20 mg dailyStandardised extractMorning
    Tincture equivalent1-2 ml daily1:5 tinctureMorning
    Assessment window3 menstrual cyclesAny standardised formDaily, including during bleeding

    Track symptoms, not feelings

    Premenstrual symptoms vary widely between cycles. A simple daily rating across three cycles is the only way to tell a real effect from natural variation.

    Evidence

    The linked evidence is a 2017 systematic review and meta-analysis in the American Journal of Obstetrics and Gynecology, pooling trials of Vitex agnus castus in premenstrual syndrome across 1,071 participants.

    Studies linked to this pairing.

    The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis

    Score: 9/10
    2017
    meta_analysis
    n=1071

    Verkaik S, Kamperman AM, van Westrhenen R +1 more

    Trials with low risk of bias yielded substantially smaller effect sizes than weaker studies of Vitex agnus castus.

    View source
    Pooled effect sizes were large, but the three trials judged at low risk of bias produced substantially smaller effects, and heterogeneity across studies was high. That pattern is the classic signature of methodological quality inflating an apparent benefit. Several included trials were also manufacturer-funded and used different extracts, so results do not transfer cleanly between products. The verdict of likely benefit rests on the smaller, more credible effect rather than the headline pooled figure.

    Safety

    Vitex is generally well tolerated. Reported effects are mild and usually transient: nausea, headache, gastrointestinal upset, acne and occasional changes in menstrual timing during the first cycles.

    Avoid in pregnancy, breastfeeding and hormone-sensitive cancer

    Vitex suppresses prolactin, which can interfere with milk production, and its hormonal activity has not been established as safe in pregnancy or in oestrogen-sensitive cancers.

    Severe premenstrual dysphoric disorder, absent periods, galactorrhoea or a confirmed high prolactin level all need medical assessment rather than self-treatment, since a pituitary cause has to be excluded. Vitex can mask the symptom without addressing the diagnosis.

    Interactions & Conflicts

    The dopaminergic action drives the interaction profile, alongside theoretical hormonal overlap with contraceptives and fertility treatment.
    Interacts withSeverityMechanismAction
    Dopamine antagonists (antipsychotics, metoclopramide)
    moderate
    		Directly opposing actions at D2 receptorsAvoid combining
    Dopamine agonists (bromocriptine, cabergoline)
    moderate
    		Additive prolactin suppressionDo not stack; prescribed treatment takes precedence
    Hormonal contraceptives
    low
    		Theoretical hormonal interferenceDiscuss with your prescriber; do not rely on vitex for cycle effects
    Fertility treatment
    moderate
    		Alters prolactin and luteal signallingOnly under specialist guidance

    References

    The citation below is the study currently linked to this pairing in our library.

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.